Developer of drug and risk analysis platform designed to generate causal hypotheses for drug efficacy and systemic toxicity.
Syntensor has raised $4.2M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in October 2024.
Syntensor's investors include Lexi Ventures.
Syntensor is headquartered in San Francisco, United States.
Developer of drug and risk analysis platform designed to generate causal hypotheses for drug efficacy and systemic toxicity.
Syntensor is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Syntensor — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/syntensor. Accessed August 14, 2026.
VCBacked. (2024). Syntensor — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/syntensor
{{cite web |title=Syntensor — Funding & Investors |url=https://www.vcbacked.co/company/syntensor |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated